Design and development of oral drugs for the prophylaxis and treatment of smallpox infectionPAINTER, George R; HOSTETLER, Karl Y.Trends in biotechnology (Regular ed.). 2004, Vol 22, Num 8, pp 423-427, issn 0167-7799, 5 p.Article

Using biomarkers to stage disease progression in a lethal mousepox model treated with CMX001PARKER, Scott; SCHRIEWER, Jill; OBERLE, Christina et al.Antiviral therapy (London). 2008, Vol 13, Num 7, pp 863-873, issn 1359-6535, 11 p.Article

Co-administration of the broad-spectrum antiviral, brincidofovir (CMX001), with smallpox vaccine does not compromise vaccine protection in mice challenged with ectromelia virusPARKER, Scott; CRUMP, Ryan; FOSTER, Scott et al.Antiviral research. 2014, Vol 111, pp 42-52, issn 0166-3542, 11 p.Article

Evaluation of disease and viral biomarkers as triggers for therapeutic intervention in respiratory mousepox - An animal model of smallpoxPARKER, Scott; CHEN, Nanhai G; SAGARTZ, John E et al.Antiviral research. 2012, Vol 94, Num 1, pp 44-53, issn 0166-3542, 10 p.Article

First Pharmacokinetic and Safety Study in Humans of the Novel Lipid Antiviral Conjugate CMX001, a Broad-Spectrum Oral Drug Active against Double-Stranded DNA VirusesPAINTER, Wendy; ROBERTSON, Alice; TROST, Lawrence C et al.Antimicrobial agents and chemotherapy. 2012, Vol 56, Num 5, pp 2726-2734, issn 0066-4804, 9 p.Article

Efficacy of therapeutic intervention with an oral ether-lipid analogue of cidofovir (CMX001) in a lethal mousepox modelPARKER, Scott; TOUCHETTE, Erin; OBERLE, Christina et al.Antiviral research. 2008, Vol 77, Num 1, pp 39-49, issn 0166-3542, 11 p.Article

Phenylpropenamide derivatives AT-61 and AT-130 inhibit replication of wild-type and lamivudine-resistant strains of hepatitis B virus in vitroDELANEY, William E; EDWARDS, Ros; COLLEDGE, Danni et al.Antimicrobial agents and chemotherapy. 2002, Vol 46, Num 9, pp 3057-3060, issn 0066-4804Article

Efficacy of CMX001 against Herpes Simplex Virus Infections in Mice and Correlations with Drug Distribution StudiesCKUENELLE, Debra C; LAMPERT, Bernhardt; COLLINS, Deborah J et al.The Journal of infectious diseases. 2010, Vol 202, Num 10, pp 1492-1499, issn 0022-1899, 8 p.Article

Esterification of cidofovir with alkoxyalkanols increases oral bioavailability and diminishes drug accumulation in kidneyCIESLA, Stephanie L; TRAHAN, Julissa; WAN, W. Brad et al.Antiviral research. 2003, Vol 59, Num 3, pp 165-171, issn 0166-3542, 7 p.Article

Synergistic efficacy of the combination of ST-246 with CMX001 against orthopoxvirusesQUENELLE, Debra C; PRICHARD, Mark N; KEITH, Kathy A et al.Antimicrobial agents and chemotherapy. 2007, Vol 51, Num 11, pp 4118-4124, issn 0066-4804, 7 p.Article

Development of Hexadecyloxypropyl Tenofovir (CMX157) for Treatment of Infection Caused by Wild-Type and Nucleoside/Nucleotide-Resistant HIVRANDALL LANIER, E; PTAK, Roger G; LAMPERT, Bernhard M et al.Antimicrobial agents and chemotherapy. 2010, Vol 54, Num 7, pp 2901-2909, issn 0066-4804, 9 p.Article

Evaluation of hexadecyloxypropyl -9 -R-[2 -(Phosphonomethoxy )propyl ]-adenine, CMX157, as a potential treatment for human immunodeficiency virus type 1 and hepatitis B virus infectionsPAINTER, George R; ALMOND, Merrick R; TROST, Lawrence C et al.Antimicrobial agents and chemotherapy. 2007, Vol 51, Num 10, pp 3505-3509, issn 0066-4804, 5 p.Article

Mechanism of action of 1-β-D-2,6-diaminopurine dioxolane, a prodrug of the human immunodeficiency virus type 1 inhibitor 1-β-D-dioxolane guanosineFURMAN, Phillip A; JEFFREY, Jerry; LIBERMAN, Irina et al.Antimicrobial agents and chemotherapy. 2001, Vol 45, Num 1, pp 158-165, issn 0066-4804Article